Ongoing projects

Diabetes mellitus type 2

DPP-4 inhibitor

Hit-to-lead
Lead optimization
Pre-clinical
Clinical Phase 1
Clinical Phase 2

Non-agonistic modulators of PPARγ

Hit-to-lead
Lead optimization
Pre-clinical
Clinical Phase 1
Clinical Phase 2

Rheumatoid arthritis and COPD

Highly specific chemokine receptor-1

Hit-to-lead
Lead optimization
Pre-clinical
Clinical Phase 1
Clinical Phase 2

Hepatocellular carcinoma and lymphoma

Histone acetyltransferase inhibitor KAT6A/B

Hit-to-lead
Lead optimization
Pre-clinical
Clinical Phase 1
Clinical Phase 2